H
Loading...
Loading...
CDC PLACES (2023, crude) estimates 13.2% of adults in St. Louis have diagnosed diabetes — 1.2 points above the U.S. 12% figure. Census population 301,578. Missouri Medicare wound biologics: WPS Government Health Administrators (J5). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed St. Louis clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a St. Louis storefront.
Diabetic Wound Care That Delivers in St. Louis, MO for clinics & physicians. Specialized diabetic wound ca… Compliance support & pricing — contact Hawk Medical.
Adult obesity in St. Louis is 36.8% (CDC PLACES 2023). That shows up in wound offloading and in joint-preservation volume — not as a slogan. CDC PLACES (2023, crude) estimates 13.2% of adults in St. Louis have diagnosed diabetes — 1.2 points above the U.S. 12% figure. Missouri is outside CDC’s core Diabetes Belt list; use the PLACES city rate anyway. Hawk Medical is the distributor for diabetic wound care, not a walk-in clinic.
National Diabetic Wound Care That Delivers notes (how the product actually works)CDC PLACES (2023, crude) estimates 13.2% of adults in St. Louis have diagnosed diabetes — 1.2 points above the U.S. 12% figure. Adult obesity in St. Louis is 36.8% (CDC PLACES 2023). That shows up in wound offloading and in joint-preservation volume — not as a slogan. Adult arthritis here is 24.2% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. Payer geography: J5 / WPS Government Health Administrators, sibling states IA, KS, NE. Missouri Department of Health & Senior Services is the public-health home. We will not mash those grains into a fake “demand score.”
If you already buy diabetic wound care elsewhere, use this page as a check: homologous-use language, current WPS Government Health Administrators article IDs, and PLACES 13.2% diabetes as the epidemiologic floor. If that is how you already practice, the catalog will fit.
CDC PLACES (2023, crude prevalence) estimates 13.2% of adults — 1.2 points above the U.S. 12% figure. Obesity is 36.8%; arthritis is 24.2%. That is place-level BRFSS modeling, not a clinic census and not a St. Louis trial.
Yes. Tissue products come from FDA-registered banks with donor screening and lot traceability. Your receiving SOP should file IFU, lot, and indication with the chart. That packet is what J5 reviewers and surveyors expect — not a brochure.
The allograft is used to perform the same basic function in the recipient as in the donor (FDA 361). Using umbilical or amniotic tissue as a marketed “stem cell cure” for unrelated conditions is outside that lane and is a Missouri compliance risk.
No. PRP (autologous) and cellular/tissue products (allograft/skin substitutes) sit on different coding and coverage paths. WPS Government Health Administrators LCDs for CTPs do not automatically cover PRP injections. Build separate protocols and fee tickets.
Ask for the IFU, the lot-traceability packet, and the WPS Government Health Administrators article IDs for the codes you actually bill. If the sales sheet cannot produce those, do not put it in a St. Louis fridge. That is how an account with us starts.
Contact us to learn how Hawk Medical supports practices in St. Louis, MO.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for St. Louis is J5 geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for St. Louis — 1.2 points above the U.S. 12% figure. Planning input, not an outcomes claim.
Missouri Part B wound biologics follow this contractor (siblings: IA, KS, NE). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in St. Louis. Useful for joint-program math; still needs a diagnosis and privileging.
No St. Louis storefront. Joe Bradley is an active practice owner. diabetic wound care stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.